Leiv Lea, Chief Financial Officer at Corvus Pharmaceuticals, Inc. (CRVS), bought 25,500 shares at $3.56 ($89K) on 2019-06-06, disclosed to the SEC on 2019-06-10.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.56 | 15,500 | $55K | 62.0% |
| 2 | $3.38 | 10,000 | $34K | 38.0% |
| Total | $3.49 avg | 25,500 | $89K | 100% |
| Filing → |
| CRVS | BUY | 2018-12-27 | $205K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $4K | — | Filing → |
| PCYC | BUY | 2007-08-22 | $6K | — | Filing → |